Zanfina Ademi

46.5k total citations · 2 hit papers
201 papers, 3.1k citations indexed

About

Zanfina Ademi is a scholar working on Economics and Econometrics, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Zanfina Ademi has authored 201 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Economics and Econometrics, 68 papers in Surgery and 45 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Zanfina Ademi's work include Health Systems, Economic Evaluations, Quality of Life (72 papers), Lipoproteins and Cardiovascular Health (34 papers) and Pharmaceutical Economics and Policy (20 papers). Zanfina Ademi is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (72 papers), Lipoproteins and Cardiovascular Health (34 papers) and Pharmaceutical Economics and Policy (20 papers). Zanfina Ademi collaborates with scholars based in Australia, United Kingdom and United States. Zanfina Ademi's co-authors include Danny Liew, Ella Zomer, Richard Ofori‐Asenso, Danijela Gašević, Alice Owen, Gerald F. Watts, Ken Lee Chin, Mohsen Mazidi, Jenni Ilomäki and Stella Talic and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Zanfina Ademi

190 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis

2021 443 citations Stella Talic, Zanfina Ademi et al. profile →
Global Incidence of Frailty and Prefrailty Among Community-Dwelling Older Adults

2019 372 citations Ella Zomer, Jenni Ilomäki et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zanfina Ademi Australia	25	814	810	558	397	395	201	3.1k
Ella Zomer Australia	27	718 0.9×	854 1.1×	488 0.9×	492 1.2×	434 1.1×	114	2.8k
Colin R. Dormuth Canada	35	1.2k 1.5×	763 0.9×	547 1.0×	408 1.0×	390 1.0×	115	4.3k
Amanda R. Patrick United States	33	1.0k 1.3×	566 0.7×	909 1.6×	339 0.9×	314 0.8×	58	3.9k
Rhonda L. Bohn United States	28	576 0.7×	695 0.9×	729 1.3×	469 1.2×	187 0.5×	83	3.5k
Steven R. Erickson United States	30	588 0.7×	371 0.5×	879 1.6×	572 1.4×	576 1.5×	133	3.3k
Jean‐Éric Tarride Canada	35	970 1.2×	1.2k 1.5×	684 1.2×	138 0.3×	557 1.4×	225	4.2k
Suzanne M. Cadarette Canada	37	525 0.6×	1.2k 1.5×	278 0.5×	275 0.7×	303 0.8×	114	4.2k
Kristijan H. Kahler United States	27	583 0.7×	480 0.6×	454 0.8×	309 0.8×	190 0.5×	72	2.9k
Corri Black United Kingdom	36	515 0.6×	526 0.6×	527 0.9×	241 0.6×	472 1.2×	94	5.0k
David Wonderling United Kingdom	25	724 0.9×	753 0.9×	464 0.8×	125 0.3×	385 1.0×	47	3.1k

Countries citing papers authored by Zanfina Ademi

Since Specialization

Citations

This map shows the geographic impact of Zanfina Ademi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zanfina Ademi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zanfina Ademi more than expected).

Fields of papers citing papers by Zanfina Ademi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zanfina Ademi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zanfina Ademi. The network helps show where Zanfina Ademi may publish in the future.

Co-authorship network of co-authors of Zanfina Ademi

This figure shows the co-authorship network connecting the top 25 collaborators of Zanfina Ademi. A scholar is included among the top collaborators of Zanfina Ademi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zanfina Ademi. Zanfina Ademi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ademi, Zanfina, Dina Abushanab, Clara Marquina, et al.. (2025). Scoping Review of Productivity-Adjusted Life Years (PALYs): Methods, Applications and Policy Implications. PharmacoEconomics. 43(12). 1367–1388.

Leung, Miriam T Y, et al.. (2025). SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta‐Analyses of Real‐World Evidence. Journal of Diabetes Research. 2025(1). 5888495–5888495.

Abushanab, Dina, Daoud Al‐Badriyeh, Danny Liew, & Zanfina Ademi. (2025). Unraveling the future productivity burden of cardiovascular disease in Qatar: Investigating the modifiable risk factors control in type 2 diabetes. American Journal of Preventive Cardiology. 22. 100961–100961. 1 indexed citations

Ademi, Zanfina, et al.. (2025). Risk of Infections with SGLT2 Inhibitors Versus DPP4 Inhibitors: A Population‐Based Cohort Study Using Antibiotic Dispensing Data. Clinical Pharmacology & Therapeutics. 118(5). 1161–1169.

Lloyd, Melanie, et al.. (2024). The productivity burden of breast cancer in Australia. Cancer Epidemiology. 94. 102726–102726. 1 indexed citations

Docking, Sean, Zanfina Ademi, Christian J. Barton, et al.. (2024). Lifetime Cost-Effectiveness of Structured Education and Exercise Therapy for Knee Osteoarthritis in Australia. JAMA Network Open. 7(10). e2436715–e2436715. 2 indexed citations

Baek, Young Min, Sandra Iuliano, John A. Robbins, et al.. (2024). Reducing hip and non-vertebral fractures in institutionalised older adults by restoring inadequate intakes of protein and calcium is cost-saving. Proceedings of The Nutrition Society. 83(OCE1). 1 indexed citations

Abushanab, Dina, Daoud Al‐Badriyeh, Clara Marquina, et al.. (2024). The reduction of the productivity burden of cardiovascular disease by improving the risk factor control Among Australians with type 2 diabetes: a 10-year dynamic analysis. European Journal of Preventive Cardiology. 33(1). 121–131. 2 indexed citations

Wen, Bo, Zanfina Ademi, Yao Wu, et al.. (2023). Productivity-adjusted life years lost due to non-optimum temperatures in Brazil: A nationwide time-series study. The Science of The Total Environment. 873. 162368–162368. 3 indexed citations

10.

Morton, Jedidiah I, Clara Marquina, Melanie Lloyd, et al.. (2023). Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis. PharmacoEconomics. 42(1). 91–107. 16 indexed citations

11.

Ademi, Zanfina, et al.. (2023). Equity in Economic Evaluations of Early Childhood Development Interventions in Low-and Middle-Income Countries: Scoping Review. Maternal and Child Health Journal. 27(6). 1009–1029. 3 indexed citations

12.

Iuliano, Sandra, et al.. (2023). Reducing hip and non-vertebral fractures in institutionalised older adults by restoring inadequate intakes of protein and calcium is cost-saving. Age and Ageing. 52(6). 3 indexed citations

13.

Abrams, Keith R., et al.. (2023). Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease. PharmacoEconomics - Open. 7(5). 777–792. 1 indexed citations

14.

Markey, Peter, Julianne Bayliss, Daryl Jones, et al.. (2023). Estimating Australian Hospitalization Ratios and Costs for Wildtype SARS-CoV-2 in 2020. Current Problems in Cardiology. 48(11). 101917–101917.

15.

Marquina, Clara, Stella Talic, Dina Abushanab, et al.. (2021). Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029. European Journal of Preventive Cardiology. 29(8). 1212–1219. 44 indexed citations

16.

Foster, Emma, Zhibin Chen, David N. Vaughan, et al.. (2021). Prospective multisite cohort study of patient‐reported outcomes in adults with new‐onset seizures. Epilepsia Open. 7(1). 201–209. 2 indexed citations

17.

Courten, Barbora de, Danny Liew, Zanfina Ademi, et al.. (2021). Productivity Benefits of Preventing Type 2 Diabetes in Australia: A 10-Year Analysis. Diabetes Care. 44(3). 715–721. 14 indexed citations

18.

Bailey, Cate, Helen Skouteris, Cheryce L. Harrison, et al.. (2020). Cost Effectiveness of Antenatal Lifestyle Interventions for Preventing Gestational Diabetes and Hypertensive Disease in Pregnancy. PharmacoEconomics - Open. 4(3). 499–510. 24 indexed citations

19.

Liew, Danny, et al.. (2020). The Health and Productivity Burden of Migraines in Australia. Headache The Journal of Head and Face Pain. 60(10). 2291–2303. 15 indexed citations

20.

Weller, Carolina, et al.. (2012). Economic evaluation of compression therapy in venous leg ulcer randomised controlled trials: A systematic review. 20(1). 21. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact